Acrux Limited
OTC: ARUXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John Warmbrunn
- Employees
- 43
- Headquarters
- West Melbourne, Australia
- IPO year
- 2010
- Market cap
- $6.8M
- Website
- https://www.acrux.com.au
Loading ARUXF…
Loading profile data…Frequently asked questions about ARUXF
What does Acrux Limited (ARUXF) do?
Acrux Limited, alongside its affiliated entities, specializes in the global development and commercialization of generic and topical pharmaceutical products. The company's reach extends across international markets, including Australia, Europe, and the United States. A significant part of its offerings includes diverse testosterone therapies, av...
Where does ARUXF trade?
Acrux Limited (ARUXF) trades on the Other OTC.
What sector is ARUXF in?
Acrux Limited (ARUXF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Acrux Limited?
John Warmbrunn is the chief executive officer of Acrux Limited (ARUXF).
Where is Acrux Limited headquartered?
Acrux Limited is headquartered in Australia.
Does ARUXF pay a dividend?
Acrux Limited (ARUXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ARUXF go public?
Acrux Limited (ARUXF) completed its initial public offering in 2010.